Anti-PD-L1 Antibody (Atezolizumab Biosimilar)
Programmed death-ligand 1 (PD-L1), also known as CD274 or B7-H1, is a transmembrane protein that plays a key role in immune regulation. By binding to PD-1 on T cells, PD-L1 inhibits T cell activation and promotes immune evasion, especially in tumors. It is widely studied as a therapeutic target in cancer immunotherapy.
Clonality:
Recombinant Human IgG
Concentration:
1 mg/mL
Reactivity:
Human
Isotype:
IgG
Form:
Liquid
Conjugation:
Unconjugated
Storage buffer:
Phosphate Buffered Saline, pH 7.4.
Storage:
This product is stable after storage at:
‧2-8°C for 2 weeks under sterile conditions from date of receipt.
‧-20°C or -80°C for 12 months under sterile conditions from date of receipt.
Avoid repeated freeze/thaw cycles.
Suggestion: Divide antibody into several vials. Keep only vials for usage at 2-8°C.
Application:
ELISA, WB, IFA, FACS
Shipping Conditions:
Blue ice
Recombinant Human IgG
Concentration:
1 mg/mL
Reactivity:
Human
Isotype:
IgG
Form:
Liquid
Conjugation:
Unconjugated
Storage buffer:
Phosphate Buffered Saline, pH 7.4.
Storage:
This product is stable after storage at:
‧2-8°C for 2 weeks under sterile conditions from date of receipt.
‧-20°C or -80°C for 12 months under sterile conditions from date of receipt.
Avoid repeated freeze/thaw cycles.
Suggestion: Divide antibody into several vials. Keep only vials for usage at 2-8°C.
Application:
ELISA, WB, IFA, FACS
Shipping Conditions:
Blue ice
Reviews for Anti-PD-L1 Antibody (Atezolizumab Biosimilar)
Average Rating: 0 (0 Reviews )